Novozymes A/S (OTCMKTS:NVZMY) Lifted to “Strong-Buy” at Berenberg Bank

Berenberg Bank upgraded shares of Novozymes A/S (OTCMKTS:NVZMY) to a strong-buy rating in a research report report published on Tuesday morning, Zacks.com reports.

Novozymes A/S Stock Up 0.9 %

OTCMKTS NVZMY opened at $71.53 on Tuesday. The company has a quick ratio of 0.80, a current ratio of 1.30 and a debt-to-equity ratio of 0.30. Novozymes A/S has a 52 week low of $38.75 and a 52 week high of $71.59. The firm has a market capitalization of $33.50 billion, a price-to-earnings ratio of 45.27, a PEG ratio of 3.98 and a beta of 0.89. The company has a fifty day moving average of $66.08 and a two-hundred day moving average of $61.85.

Novozymes A/S Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Wednesday, September 18th. Shareholders of record on Monday, September 9th were given a $0.1678 dividend. The ex-dividend date of this dividend was Monday, September 9th. Novozymes A/S’s dividend payout ratio (DPR) is presently 41.77%.

About Novozymes A/S

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services.